Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen by Szudy-Szczyrek, Aneta, Mlak, Radosław, Mielnik, Michał, Szczyrek, Michał, Nowaczyńska, Aleksandra, Homa-Mlak, Iwona, Zmorzyński, Szymon, Kuśmierczuk, Kinga, Sompor, Jacek, Filip, Agata, Małecka-Massalska, Teresa, Hus, Marek

Get full text

Chemotherapy-Related Differences in Cognitive Functioning and Their Biological Predictors in Patients with Multiple Myeloma by Bury-Kamińska, Magdalena, Szudy-Szczyrek, Aneta, Nowaczyńska, Aleksandra, Jankowska-Łęcka, Olga, Hus, Marek, Kot, Klaudia

Get full text

Minimally invasive, endovenous laser treatment of varicose veins in patients with von Willebrand disease by Terlecki, Piotr, Zubilewicz, Tomasz, Przywara, Stanisław, Iłżecki, Marek, Karakuła, Wacław, Hus, Marek, Nowaczyńska, Aleksandra, Kuczyński, Maciej

Get full text

Changes in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory ce... by Podhorecka, Monika, Goracy, Aneta, Szymczyk, Agnieszka, Kowal, Malgorzata, Ibanez, Blanca, Jankowska-Lecka, Olga, Macheta, Arkadiusz, Nowaczynska, Aleksandra, Drab-Urbanek, Elzbieta, Chocholska, Sylwia, Jawniak, Dariusz, Hus, Marek

Get full text

JAK2 mutation status, hemostatic risk factors and thrombophilic factors in essential thrombocythemia (ET) patients by Sokołowska, Bożena, Nowaczyńska, Aleksandra, Bykowska, Ksenia, Chocholska, Sylwia, Wejksza, Katarzyna, Walter-Croneck, Adam, Gromek, Tomasz, Kowalska, Anna M, Kandefer-Szerszeń, Martyna, Dmoszyńska, Anna

Get full text

Efficacy and Safety of Biosimilar G-CSF and Originator G-CSF for Haematopoietic Stem Cell Mobilisation: A Randomised Comparison by Dmoszynska, Anna, Manko, Joanna, Walter Croneck, Adam, Grzasko, Norbert, Klimek, Piotr, Nowaczynska, Aleksandra, Gorska-Kosicka, Magdalena

Get full text

Assessment of Plasma Prothrombotic Factors in Patients with Buerger's Disease by Hus, Iwona, Sokolowska, Bozena, Chrapko, Marek, Nowaczynska, Aleksandra, Walter-Croneck, Adam, Mazurek, Kamila, Lewandowska, Magdalena, Rolinski, Jacek M., Dmoszynska, Anna

Get full text

JAK2 Mutational Status, Hemostatic Risk Factors and Thrombophilic Factors in Essential Thrombocythemia (ET) Patients by Sokolowska, Bozena, Nowaczynska, Aleksandra, Bykowska, Ksenia, Chocholowska, Sylwia, Wejksza, Katarzyna, Walter-Cronack, Adam, Kandefer-Szerszen, Martyna, Gromek, Tomasz, Kowalska, M. Anna, Dmoszynska, Anna

Get full text

Fibrinolytic Activity in Patients with Essential Thrombocythemia by Sokolowska, Bozena, Nowaczynska, Aleksandra, Wejksza, Katarzyna, Walter-Croneck, Adam, Kandefer-Szerszen, Martyna, Gromek, Tomasz, Kowalska, M. Anna, Dmoszynska, Anna

Get full text

Combined Schedule of Fludarabine and Alemtuzumab Followed by Maintenance with Low-Dose Alemtuzumab Is Effective for Patients with Progressive B-Cell Chronic Lymphocytic Leukemia by Kowal, Malgorzata, Nowak, Wieslaw, Nowaczynska, Aleksandra, Dmoszynska, Anna, Skotnicki, Aleksander B.

Get full text

JAK2 mutation status, hemostatic risk factors and thrombophilic factors in essential thrombocythemia (ET) patients by Anna Dmoszyńska, Martyna Kandefer-Szerszeń, Anna M. Kowalska, Tomasz Gromek, Adam Walter-Croneck, Katarzyna Wejksza, Sylwia Chocholska, Ksenia Bykowska, Aleksandra Nowaczyńska, Bożena Sokołowska

Get full text